AbbVie Immunology is dedicated to identifying break-through therapies for inflammatory and auto-immune diseases that will have a remarkable impact on patients' lives. The Molecular Pharmacology group is seeking an associate scientist responsible for conducting in vitro studies on the characterization of drug candidate molecules and the validation of drug targets.
Design and perform biochemical and cellular studies of drug potency and mechanism of action
Analysis and interpretation of quantitative data
Effectively organize and communicate research progress and activities through oral and written presentations
Read and apply relevant scientific literature
Maintenance of accurate and current records of research
Level and compensation will be commensurate with experience.
B.S. OR M.S. in Biochemistry, Molecular Biology, Cell Biology, or a related discipline
Experience with cellular assays: 2nd messenger, proliferation, phospho-protein analysis, gene reporter, and release of soluble mediators
Experience with biochemical assays: enzymatic activity, binding
Experience with cell culture and the preparation and testing of primary immune cells
Highly motivated, detail-oriented, curious of the science, and desiring to learn novel in vitro pharmacology techniques
Experience with use of laboratory automation equipment
Strong IT skills and familiarity with spreadsheets and curve-fitting programs
Candidate must be highly collaborative and thrive in a dynamic, multi-disciplinary environment.
Strong organizational, communication, and inter-personal skills
3+ (BS) or 0+ (MS) years of relevant lab experience
Key Leadership Qualifications:
Builds strong relationships with peers and cross-functionally with partners outside of team to enable higher performance
Learns fast, grasps the \"essence\" and can change course quickly where indicated
Raises the bar and is never satisfied with the status quo
Creates a learning environment, open to suggestions and experimentation for improvement
Embraces the ideas of others, nurtures innovation and manages innovation to reality